OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune vulnerabilities of mutant KRAS in pancreatic cancer
Noah Cheng, Robert H. Vonderheide
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 928-936
Open Access | Times Cited: 10
Noah Cheng, Robert H. Vonderheide
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 928-936
Open Access | Times Cited: 10
Showing 10 citing articles:
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
Anna Linehan, Mary O’Reilly, Ray McDermott, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 13
Anna Linehan, Mary O’Reilly, Ray McDermott, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 13
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers
Snigdha Banerjee, Affan A. Ansari, Sunil P. Upadhyay, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 395-395
Open Access | Times Cited: 7
Snigdha Banerjee, Affan A. Ansari, Sunil P. Upadhyay, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 395-395
Open Access | Times Cited: 7
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access
Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer
Kai Nan, Lei Zhang, Yujia Zou, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 123-138
Open Access
Kai Nan, Lei Zhang, Yujia Zou, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 123-138
Open Access
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in Therapeutic Implication of Cancers
Snigdha Banerjee, Affan A. Ansari, Sunil P. Upadhyay, et al.
(2024)
Open Access | Times Cited: 4
Snigdha Banerjee, Affan A. Ansari, Sunil P. Upadhyay, et al.
(2024)
Open Access | Times Cited: 4
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Precursor lesions in familial and hereditary pancreatic cancer
Michael J. Pflüger, Lodewijk A.A. Brosens, Ralph H. Hruban
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 267-278
Closed Access | Times Cited: 2
Michael J. Pflüger, Lodewijk A.A. Brosens, Ralph H. Hruban
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 267-278
Closed Access | Times Cited: 2
The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer
Sherise C. Rogers, Angel Charles, Ryan M. Thomas
Cancers (2023) Vol. 15, Iss. 24, pp. 5708-5708
Open Access | Times Cited: 4
Sherise C. Rogers, Angel Charles, Ryan M. Thomas
Cancers (2023) Vol. 15, Iss. 24, pp. 5708-5708
Open Access | Times Cited: 4
Targeted KRASG12Vdegradation elicits efficient and durable lung adenocarcinoma regressionin vivo
Alberto J. M. Martín, Inmaculada García-Peréz, Sonia San José, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alberto J. M. Martín, Inmaculada García-Peréz, Sonia San José, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape
Lixing Li, Lu Shen, Hao Wu, et al.
Carcinogenesis (2023)
Closed Access | Times Cited: 1
Lixing Li, Lu Shen, Hao Wu, et al.
Carcinogenesis (2023)
Closed Access | Times Cited: 1
